Methods in Molecular Biology, ISSN 1064-3745, 2010, Volume 635, pp. 261 - 280
Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence-guided tumour resection (FGR) and photodynamic therapy (PDT) are currently...
Foscan | Photodynamic therapy | Malignant brain tumour | Neurosurgery | Photofrin | 5-ALA | Fluorescence-guided resection | Animals | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Brain Neoplasms - diagnosis | Humans | Spectrometry, Fluorescence | Clinical Trials as Topic | Brain Neoplasms - drug therapy
Foscan | Photodynamic therapy | Malignant brain tumour | Neurosurgery | Photofrin | 5-ALA | Fluorescence-guided resection | Animals | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Brain Neoplasms - diagnosis | Humans | Spectrometry, Fluorescence | Clinical Trials as Topic | Brain Neoplasms - drug therapy
Conference Proceeding
2016, Comprehensive series in photochmistry and photobiology, ISBN 9781782626824, Volume 15
Web Resource
2016, Comprehensive series in photochmistry and photobiology, ISBN 9781782626824, Volume 15
Web Resource
2003, Comprehensive series in photochemistry & photobiology, ISBN 0854043063, Volume 2., xiv, 284
Written by recognised experts, Photodynamic Therapy provides a comprehensive explanation of what PDT is and how it has developed as a technique..
Photochemotherapy | Nursing & Ancillary Services | Life Sciences | Science | General | Chemistry | Biochemistry
Photochemotherapy | Nursing & Ancillary Services | Life Sciences | Science | General | Chemistry | Biochemistry
Book
Photonics & Lasers in Medicine, ISSN 2193-0635, 02/2015, Volume 4, Issue 1, pp. 11 - 12
Journal Article
Proceedings of SPIE - The International Society for Optical Engineering, ISSN 0277-786X, 07/2009, Volume SPIE-7380
Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence guided tumor resection (FGR) and photodynamic therapy (PDT) are currently undergoing...
Journal Article
Proceedings of SPIE - The International Society for Optical Engineering, ISSN 0277-786X, 07/2009, Volume 7380
Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence guided tumor resection (FGR) and photodynamic therapy (PDT) are currently undergoing...
Journal Article
Progress in Biomedical Optics and Imaging - Proceedings of SPIE, ISSN 1605-7422, 2009, Volume 7380
Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence guided tumor resection (FGR) and photodynamic therapy (PDT) are currently undergoing...
malignant brain tumors | glioblastoma multiforme | Fluorescence guided resection | Photodynamic Diagnosis | Photodynamic Therapy | neurosurgery
malignant brain tumors | glioblastoma multiforme | Fluorescence guided resection | Photodynamic Diagnosis | Photodynamic Therapy | neurosurgery
Conference Proceeding
Photodiagnosis and Photodynamic Therapy, ISSN 1572-1000, 2011, Volume 8, Issue 2, pp. 105 - 106
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 06/2011, Volume 52, Issue 6, pp. 856 - 864
The objective of this study was to compare MRI response assessment with metabolic O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) PET response evaluation during...
F-FET PET response assessment | Recurrent high-grade glioma | MRI response criteria | Antiangiogenic treatment | CRITERIA | BEVACIZUMAB | MRI | antiangiogenic treatment | TUMOR ANGIOGENESIS | F-18-FET PET response assessment | recurrent high-grade glioma | CHEMOTHERAPY | GLIOBLASTOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | TREATMENT RESPONSE | IRINOTECAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Tyrosine - analogs & derivatives | Bevacizumab | Antibodies, Monoclonal, Humanized | Astrocytoma - pathology | Treatment Failure | Astrocytoma - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Nervous System Diseases - physiopathology | Retrospective Studies | Glioma - surgery | Radiopharmaceuticals | Camptothecin - analogs & derivatives | Postoperative Complications - physiopathology | Camptothecin - therapeutic use | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Magnetic Resonance Imaging | Glioma - diagnostic imaging | Image Processing, Computer-Assisted | Survival Analysis | Nervous System Diseases - etiology | Glioma - drug therapy | Astrocytoma - surgery | Medical imaging | Clinical medicine | Permeability | Vascular endothelial growth factor | Brain cancer | Tumors
F-FET PET response assessment | Recurrent high-grade glioma | MRI response criteria | Antiangiogenic treatment | CRITERIA | BEVACIZUMAB | MRI | antiangiogenic treatment | TUMOR ANGIOGENESIS | F-18-FET PET response assessment | recurrent high-grade glioma | CHEMOTHERAPY | GLIOBLASTOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | TREATMENT RESPONSE | IRINOTECAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Tyrosine - analogs & derivatives | Bevacizumab | Antibodies, Monoclonal, Humanized | Astrocytoma - pathology | Treatment Failure | Astrocytoma - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Nervous System Diseases - physiopathology | Retrospective Studies | Glioma - surgery | Radiopharmaceuticals | Camptothecin - analogs & derivatives | Postoperative Complications - physiopathology | Camptothecin - therapeutic use | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Magnetic Resonance Imaging | Glioma - diagnostic imaging | Image Processing, Computer-Assisted | Survival Analysis | Nervous System Diseases - etiology | Glioma - drug therapy | Astrocytoma - surgery | Medical imaging | Clinical medicine | Permeability | Vascular endothelial growth factor | Brain cancer | Tumors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2008, Volume 14, Issue 1, pp. 130 - 138
Purpose: The receptor tyrosine kinase Axl has recently been identified as a critical element in the invasive properties of glioma cell lines. However, the...
glioblastoma multiforme | targeted therapy | glioma | receptor tyrosine kinase | Axl | CELLS | ACTIVATION | SURVIVAL PATHWAY | CORTICAL-NEURONS | ONCOLOGY | INDUCED APOPTOSIS | GAS6 | EXPRESSION | TUMORS | RECEPTOR TYROSINE KINASE | VASCULAR SMOOTH-MUSCLE | Immunohistochemistry | Gene Expression | Prognosis | Tissue Array Analysis | Humans | Middle Aged | Receptor Protein-Tyrosine Kinases - biosynthesis | Brain Neoplasms - pathology | Kaplan-Meier Estimate | RNA, Messenger - analysis | Intercellular Signaling Peptides and Proteins - biosynthesis | Male | Reverse Transcriptase Polymerase Chain Reaction | Brain Neoplasms - metabolism | Disease-Free Survival | Glioblastoma - pathology | Oncogene Proteins - biosynthesis | Survival Analysis | Female | Glioblastoma - metabolism | Proto-Oncogene Proteins | Brain Neoplasms - mortality | Glioblastoma - mortality
glioblastoma multiforme | targeted therapy | glioma | receptor tyrosine kinase | Axl | CELLS | ACTIVATION | SURVIVAL PATHWAY | CORTICAL-NEURONS | ONCOLOGY | INDUCED APOPTOSIS | GAS6 | EXPRESSION | TUMORS | RECEPTOR TYROSINE KINASE | VASCULAR SMOOTH-MUSCLE | Immunohistochemistry | Gene Expression | Prognosis | Tissue Array Analysis | Humans | Middle Aged | Receptor Protein-Tyrosine Kinases - biosynthesis | Brain Neoplasms - pathology | Kaplan-Meier Estimate | RNA, Messenger - analysis | Intercellular Signaling Peptides and Proteins - biosynthesis | Male | Reverse Transcriptase Polymerase Chain Reaction | Brain Neoplasms - metabolism | Disease-Free Survival | Glioblastoma - pathology | Oncogene Proteins - biosynthesis | Survival Analysis | Female | Glioblastoma - metabolism | Proto-Oncogene Proteins | Brain Neoplasms - mortality | Glioblastoma - mortality
Journal Article
Neuroradiology, ISSN 0028-3940, 4/2011, Volume 53, Issue 4, pp. 291 - 302
The purpose of this study is to evaluate apparent diffusion coefficient (ADC) maps to distinguish anti-vascular and anti-tumor effects in the course of...
Neurology | ADC histograms | Neurosciences | Anti-angiogenic therapy | Medicine & Public Health | Skewness | DWI-MRI | Neurosurgery | Imaging / Radiology | Recurrent high-grade glioma | Neuroradiology | GLIOBLASTOMA-MULTIFORME | PROGRESSION-FREE SURVIVAL | PHASE-II | APPARENT DIFFUSION-COEFFICIENT | NEUROIMAGING | CANCER-THERAPY | CLINICAL NEUROLOGY | BRAIN-TUMORS | MALIGNANT GLIOMA | CLINICAL-TRIALS | DRUG DEVELOPMENT | END-POINTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrence | Prognosis | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols | Male | Treatment Outcome | Brain Neoplasms - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal - administration & dosage | Glioma - pathology | Adult | Camptothecin - administration & dosage | Female | Aged | Retrospective Studies | Diffusion Magnetic Resonance Imaging - methods | Glioma - drug therapy | Camptothecin - analogs & derivatives | Antimitotic agents | Medical colleges | Medical research | Relapse | Image processing | Gliomas | Medicine, Experimental | Antineoplastic agents | Diseases | Radiology | Angiogenesis | Histograms | Nuclear magnetic resonance--NMR
Neurology | ADC histograms | Neurosciences | Anti-angiogenic therapy | Medicine & Public Health | Skewness | DWI-MRI | Neurosurgery | Imaging / Radiology | Recurrent high-grade glioma | Neuroradiology | GLIOBLASTOMA-MULTIFORME | PROGRESSION-FREE SURVIVAL | PHASE-II | APPARENT DIFFUSION-COEFFICIENT | NEUROIMAGING | CANCER-THERAPY | CLINICAL NEUROLOGY | BRAIN-TUMORS | MALIGNANT GLIOMA | CLINICAL-TRIALS | DRUG DEVELOPMENT | END-POINTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrence | Prognosis | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols | Male | Treatment Outcome | Brain Neoplasms - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal - administration & dosage | Glioma - pathology | Adult | Camptothecin - administration & dosage | Female | Aged | Retrospective Studies | Diffusion Magnetic Resonance Imaging - methods | Glioma - drug therapy | Camptothecin - analogs & derivatives | Antimitotic agents | Medical colleges | Medical research | Relapse | Image processing | Gliomas | Medicine, Experimental | Antineoplastic agents | Diseases | Radiology | Angiogenesis | Histograms | Nuclear magnetic resonance--NMR
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2012, Volume 48, Issue 14, pp. 2192 - 2202
Purpose: NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour...
Brain tumour | Chemotherapy | Randomised trial | Glioblastoma | ONCOLOGY | ELECTRIC-FIELDS | MALIGNANT GLIOMAS | REOPERATION | COMBINATION | MULTIFORME | TEMOZOLOMIDE | United States | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Young Adult | Karnofsky Performance Status | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Brain Neoplasms - drug therapy | Glioblastoma - therapy | Disease-Free Survival | Magnetic Resonance Imaging | Electric Stimulation Therapy - adverse effects | Glioblastoma - pathology | Brain Neoplasms - therapy | Quality of Life | Aged | Israel | Glioblastoma - drug therapy | Glioblastoma - mortality | Medical colleges | Neurosciences | Brain tumors | Clinical trials | Glioblastoma multiforme | Biometry | Cancer | Index Medicus
Brain tumour | Chemotherapy | Randomised trial | Glioblastoma | ONCOLOGY | ELECTRIC-FIELDS | MALIGNANT GLIOMAS | REOPERATION | COMBINATION | MULTIFORME | TEMOZOLOMIDE | United States | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Young Adult | Karnofsky Performance Status | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Brain Neoplasms - drug therapy | Glioblastoma - therapy | Disease-Free Survival | Magnetic Resonance Imaging | Electric Stimulation Therapy - adverse effects | Glioblastoma - pathology | Brain Neoplasms - therapy | Quality of Life | Aged | Israel | Glioblastoma - drug therapy | Glioblastoma - mortality | Medical colleges | Neurosciences | Brain tumors | Clinical trials | Glioblastoma multiforme | Biometry | Cancer | Index Medicus
Journal Article
Wiener Medizinische Wochenschrift, ISSN 0043-5341, 1/2011, Volume 161, Issue 1, pp. 20 - 21
Bei PatientInnen mit rezidivierten malignen Gliomen gibt es auch für das neurochirurgische Vorgehen keine akkordierten Standards. Zur Entscheidungsfindung hat...
Neurochirurgische Intervention | Neurosurgical intervention | Geriatrics/Gerontology | Individualized approach | General Practice / Family Medicine | Internal Medicine | Medicine/Public Health, general | 5-Ala in vivo fluoreszenz | Medicine & Public Health | Recurrent malignant glioma | Infectious Diseases | Pharmacology/Toxicology | 5-Ala in vivo fluorescence | Rezidiviertes malignes Gliom | Individualisiertes Vorgehen | Reoperation | Prognosis | Humans | Brain Neoplasms - pathology | Neuronavigation | Survival Rate | Combined Modality Therapy | Tumor Burden | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Glioblastoma - surgery | Neoplasm Recurrence, Local - pathology | Photosensitizing Agents | Glioblastoma - pathology | Quality of Life | Brain Neoplasms - mortality | Aminolevulinic Acid | Glioblastoma - mortality | Microscopy, Fluorescence | Fluorescence | Gliomas
Neurochirurgische Intervention | Neurosurgical intervention | Geriatrics/Gerontology | Individualized approach | General Practice / Family Medicine | Internal Medicine | Medicine/Public Health, general | 5-Ala in vivo fluoreszenz | Medicine & Public Health | Recurrent malignant glioma | Infectious Diseases | Pharmacology/Toxicology | 5-Ala in vivo fluorescence | Rezidiviertes malignes Gliom | Individualisiertes Vorgehen | Reoperation | Prognosis | Humans | Brain Neoplasms - pathology | Neuronavigation | Survival Rate | Combined Modality Therapy | Tumor Burden | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Glioblastoma - surgery | Neoplasm Recurrence, Local - pathology | Photosensitizing Agents | Glioblastoma - pathology | Quality of Life | Brain Neoplasms - mortality | Aminolevulinic Acid | Glioblastoma - mortality | Microscopy, Fluorescence | Fluorescence | Gliomas
Journal Article
2014, 20
Reference
Photochemistry and Photobiology, ISSN 0031-8655, 2001, Volume 74, Issue 4, pp. 611 - 616
Abstract Radical tumor resection is the basis for the prolonged survival of patients suffering from malignant brain tumors such as glioblastoma multiforme. We...
INDUCED PORPHYRIN FLUORESCENCE | PROTOPORPHYRIN | THERAPY | TETRAHYDROXYPHENYLCHLORIN | BIOPHYSICS | SPECTROSCOPY | GLIOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | EARLY CANCERS | LASER-INDUCED FLUORESCENCE | 5-AMINOLEVULINIC ACID | GUIDED RESECTION | Glioma - diagnosis | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Phototherapy - instrumentation | Antineoplastic Agents - therapeutic use | Brain Neoplasms - surgery | Feasibility Studies | Dose-Response Relationship, Drug | Radiation-Sensitizing Agents - therapeutic use | Phototherapy - methods | Sensitivity and Specificity | Glioma - therapy | Adult | Female | Glioma - surgery | Mesoporphyrins - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Brain Neoplasms - diagnosis | Combined Modality Therapy | Brain Neoplasms - drug therapy | Microscopy, Fluorescence - methods | Intraoperative Care | Brain Neoplasms - therapy | Aged | Glioma - drug therapy | Clinical Trials, Phase II as Topic
INDUCED PORPHYRIN FLUORESCENCE | PROTOPORPHYRIN | THERAPY | TETRAHYDROXYPHENYLCHLORIN | BIOPHYSICS | SPECTROSCOPY | GLIOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | EARLY CANCERS | LASER-INDUCED FLUORESCENCE | 5-AMINOLEVULINIC ACID | GUIDED RESECTION | Glioma - diagnosis | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Phototherapy - instrumentation | Antineoplastic Agents - therapeutic use | Brain Neoplasms - surgery | Feasibility Studies | Dose-Response Relationship, Drug | Radiation-Sensitizing Agents - therapeutic use | Phototherapy - methods | Sensitivity and Specificity | Glioma - therapy | Adult | Female | Glioma - surgery | Mesoporphyrins - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Brain Neoplasms - diagnosis | Combined Modality Therapy | Brain Neoplasms - drug therapy | Microscopy, Fluorescence - methods | Intraoperative Care | Brain Neoplasms - therapy | Aged | Glioma - drug therapy | Clinical Trials, Phase II as Topic
Journal Article
Methods, ISSN 1046-2023, 2011, Volume 55, Issue 3, pp. 223 - 229
The management of high-grade glioma (HGG) patients in clinical routine represents a challenging task. HGG has a poor prognosis because of early recurrence or...
PRRT | High-grade glioma | Treatment | Radiolabeled peptides | Glioblastoma | NERVOUS-SYSTEM | GA-68-DOTA-TYR-OCTREOTIDE PET | GLIOBLASTOMA-MULTIFORME | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECURRENT GLIOBLASTOMA | BIOCHEMICAL RESEARCH METHODS | SOMATOSTATIN RECEPTORS | BRAIN-TUMORS | MALIGNANT GLIOMAS | RADIOTHERAPY | SUBSTANCE-P | MEDIATED RADIONUCLIDE THERAPY | Glioma - diagnosis | Humans | Treatment Outcome | Positron-Emission Tomography - methods | Peptides - administration & dosage | Glioma - metabolism | Radiopharmaceuticals - administration & dosage | Radiopharmaceuticals - metabolism | Animals | Peptides - metabolism | Clinical Trials as Topic - methods | Glioma - drug therapy | Receptors, Peptide - metabolism | Chemotherapy | Peptides | Gliomas | Nuclear radiation | Glycoproteins | Drug therapy | Radiotherapy | Cancer
PRRT | High-grade glioma | Treatment | Radiolabeled peptides | Glioblastoma | NERVOUS-SYSTEM | GA-68-DOTA-TYR-OCTREOTIDE PET | GLIOBLASTOMA-MULTIFORME | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECURRENT GLIOBLASTOMA | BIOCHEMICAL RESEARCH METHODS | SOMATOSTATIN RECEPTORS | BRAIN-TUMORS | MALIGNANT GLIOMAS | RADIOTHERAPY | SUBSTANCE-P | MEDIATED RADIONUCLIDE THERAPY | Glioma - diagnosis | Humans | Treatment Outcome | Positron-Emission Tomography - methods | Peptides - administration & dosage | Glioma - metabolism | Radiopharmaceuticals - administration & dosage | Radiopharmaceuticals - metabolism | Animals | Peptides - metabolism | Clinical Trials as Topic - methods | Glioma - drug therapy | Receptors, Peptide - metabolism | Chemotherapy | Peptides | Gliomas | Nuclear radiation | Glycoproteins | Drug therapy | Radiotherapy | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 03/2010, Volume 51, Issue 3, pp. 397 - 400
Journal Article
Wiener Medizinische Wochenschrift, ISSN 0043-5341, 06/2006, Volume 156, Issue 11-12, pp. 338 - 341
Journal Article
Wiener Medizinische Wochenschrift, ISSN 0043-5341, 6/2006, Volume 156, Issue 11, pp. 338 - 341
Glialtumors occur at an incidence from 2 to 10/ 100.000 (Japan vs. Sweden) and building up to 50 % of all patients suffering from braintumors. 50 % of those...
Maligne Gliome | Geriatrics/Gerontology | Neuronavigation | General Practice / Family Medicine | Internal Medicine | Neurosurgery | Medicine/Public Health, general | Neuronavigantion | Neurochirurgie | Malignant glioma | Medicine & Public Health | Infectious Diseases | Pharmacology/Toxicology
Maligne Gliome | Geriatrics/Gerontology | Neuronavigation | General Practice / Family Medicine | Internal Medicine | Neurosurgery | Medicine/Public Health, general | Neuronavigantion | Neurochirurgie | Malignant glioma | Medicine & Public Health | Infectious Diseases | Pharmacology/Toxicology
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.